TFBS Bioscience Inc. (TPEX:6939)
Taiwan · Delayed Price · Currency is TWD 19.05
-0.65 (-3.30%)
Oct 8, 2026, 2:58 PM CST
TFBS Bioscience Market Cap
TFBS Bioscience has a market cap or net worth of 665.59 million as of October 9, 2026. It is the 36,840th most valuable company in the world and the 2,195th biggest in Taiwan. Its market cap has decreased by 21.12% in one year.
Market Cap
665.59M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,195 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since May 15, 2023, TFBS Bioscience's market cap has decreased from 2.35B to 665.59M, a decrease of -71.66%. That is a compound annual growth rate of -30.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 665.59M | -10.98% |
| Dec 31, 2025 | 747.70M | -24.34% |
| Dec 31, 2024 | 988.18M | -39.96% |
| Dec 29, 2023 | 1.65B | -29.93% |
| May 15, 2023 | 2.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| DIVA Laboratories | 1.81B |
| Genetics Generation Advancement | 1.09B |
| Puriblood Medical | 1.06B |
| Kim Forest Enterprise | 815.18M |
| Sofiva Genomics | 720.14M |
| Welgene Biotech | 400.83M |
| Pharmigene | 373.44M |